Unique features of human cathelicidin LL‐37
- 10 September 2015
- journal article
- review article
- Published by Wiley in BioFactors
- Vol. 41 (5), 289-300
- https://doi.org/10.1002/biof.1225
Abstract
Cathelicidins are antimicrobial peptides produced by humans and animals in response to various pathogenic microbes. This review intends to provide a brief overview of the expression, structure, properties and function of human cathelicidin LL-37 which may be a therapeutic agent against a variety of bacterial and viral diseases, cancers, and hard-to-heal wounds. Cathelicidins act as a primary defense against bacteria and other pathogens in the case of inflammation. They are able to kill bacteria and fungi, inhibit and destroy bacterial biofilms, and possess antiviral and antiparasitics properties. They can also play a role in angiogenesis, wound healing, and the regulation of apoptosis. The host defense peptide LL-37 has emerged as a novel modulator of tumor growth and metastasis in carcinogenesis of various types of cancers. LL-37 is an antimicrobial peptide able of inducing various effects. It acts as an anti- and pro- inflammatory factor. Cathelicidins are able to directly and selectively destroy membranes of various microbes and cancer cells, but they do not attack normal cells. The role of cathelicidins in cancer is double-sided. They play an important role in killing cancer cells and may provide a new possibility for the development of cancer therapeutics. However, they also can participate in carcinogenesis. Due to its activity spectrum LL-37 could be applied in pharmacotherapy. Cathelicidin peptides could serve as a template for the development of modern anti-microbial and anti-viral drugs. LL-37 is an excellent candidate to develop into therapeutics for infected wounds. © 2015 BioFactors, 41(5):289–300, 2015Keywords
This publication has 103 references indexed in Scilit:
- Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 LigandsJournal of Investigative Dermatology, 2012
- The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantationLeukemia, 2011
- Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coliPeptides, 2010
- Emerging roles of the host defense peptide LL‐37 in human cancer and its potential therapeutic applicationsInternational Journal of Cancer, 2010
- Kallikrein Expression and Cathelicidin Processing Are Independently Controlled in Keratinocytes by Calcium, Vitamin D3, and Retinoic AcidJournal of Investigative Dermatology, 2010
- The antimicrobial peptide LL‐37 modulates the inflammatory and host defense response of human neutrophilsEuropean Journal of Immunology, 2010
- Alarmins link neutrophils and dendritic cellsTrends in Immunology, 2009
- Differing effects of exogenous or endogenous cathelicidin on macrophage toll‐like receptor signalingImmunology & Cell Biology, 2009
- Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D3Journal of Cystic Fibrosis, 2007
- Antimicrobial peptides of multicellular organismsNature, 2002